01161nam a22001457a 4500100008400000245008900084260009900173300000900272490002200281520054100303650004900844856010000893942000700993999001501000  aInter-Governmental Action Group against Money Laundering in West Africa (GIABA)  aMoney Laundering Resulting from the Counterfeiting of Pharmaceuticals in West Africa  aSenegalbInter-Governmental Action Group against Money Laundering in West Africa (GIABA)c2017  a56p.  aTypologies Report  aThis study, published by Inter-Governmental Action Group against Money Laundering in West Africa (GIABA) is aimed at understanding the nature and magnitude of money laundering in West Africa as a result of counterfeiting pharmaceuticals. The study encourages countries to reorganise approaches in tracking, tracing and encoding legitimate products. Based on the findings of the study, one of the recommendations made is that law enforcement and regulatory officials involved in counterfeit pharmaceuticals should be adequately trained.   aMoney Laundering, Illicit Wealth, Corruption  uiffoadatabase.trustafrica.org/iff/GIABA_Typologies_Report_ML_and_Counterfeit_Pharmaceutical.pdf  cCF  c1045d1045